Key Financial Data Of Group

WAKAMOTO PHARMACEUTICAL CO.,LTD. - Filing #7256444

Concept As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
Key financial data of group
Business results of group
Net sales
7,789,462,000 JPY
7,738,426,000 JPY
8,660,379,000 JPY
8,383,145,000 JPY
8,895,838,000 JPY
Ordinary profit (loss)
-409,238,000 JPY
-161,857,000 JPY
242,574,000 JPY
72,259,000 JPY
-604,961,000 JPY
Net assets
11,610,351,000 JPY
12,026,073,000 JPY
11,906,669,000 JPY
11,480,803,000 JPY
11,385,570,000 JPY
Total assets
15,002,709,000 JPY
15,421,054,000 JPY
15,711,553,000 JPY
14,953,435,000 JPY
14,572,472,000 JPY
Net assets per share
334.53
346.50
343.06
330.79
328.04
Basic earnings (loss) per share
1.85
3.13
3.98
6.87
-17.34
Diluted earnings per share
Equity-to-asset ratio
0.7739 xbrli:pure
0.7798 xbrli:pure
0.7578 xbrli:pure
0.7677 xbrli:pure
0.7813 xbrli:pure
Rate of return on equity
0.0055 xbrli:pure
0.0091 xbrli:pure
0.0118 xbrli:pure
0.0209 xbrli:pure
-0.0516 xbrli:pure
Price-earnings ratio
171.35 xbrli:pure
72.52 xbrli:pure
62.06 xbrli:pure
42.06 xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-592,454,000 JPY
-107,338,000 JPY
631,920,000 JPY
339,174,000 JPY
163,438,000 JPY
Net cash provided by (used in) investing activities
-13,498,000 JPY
-2,352,000 JPY
17,131,000 JPY
50,572,000 JPY
-199,513,000 JPY
Net cash provided by (used in) financing activities
-103,935,000 JPY
-104,986,000 JPY
-1,615,000 JPY
-1,620,000 JPY
-3,829,000 JPY
Cash and cash equivalents
2,954,759,000 JPY
3,664,647,000 JPY
3,879,325,000 JPY
3,231,889,000 JPY
2,843,762,000 JPY
Number of employees
xbrli:pure
15 xbrli:pure
167 xbrli:pure
286 xbrli:pure
6 xbrli:pure
98 xbrli:pure
274 xbrli:pure
292 xbrli:pure
300 xbrli:pure
306 xbrli:pure
Average number of temporary employees
xbrli:pure
5 xbrli:pure
79 xbrli:pure
118 xbrli:pure
3 xbrli:pure
31 xbrli:pure
100 xbrli:pure
90 xbrli:pure
87 xbrli:pure
100 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.